RO7034067, Evrysdi 0.75 mg/mL powder for oral solution
BN44620
Approved small_molecule active
Quick answer
RO7034067, Evrysdi 0.75 mg/mL powder for oral solution for Spinal Muscular Atrophy (SMA) is a Approved program (small_molecule) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hoffmann-La Roche
- Indication
- Spinal Muscular Atrophy (SMA)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active